Synthesis of 5,5′-dithiobis(2-nitrobenzamides) as alternative substrates for trypanothione reductase and thioredoxin reductase:: A microtiter colorimetric assay for inhibitor screening

被引:20
作者
Davioud-Charvet, E
Becker, K
Landry, V
Gromer, S
Logé, C
Sergheraert, C
机构
[1] Inst Pasteur Lille, Inst Biol, CNRS, URA 1309, F-59021 Lille, France
[2] Univ Heidelberg, Ctr Biochem, D-69120 Heidelberg, Germany
关键词
drug design; Chagas' disease; malaria; Plasmodium falciparum; thioredoxin reductase; Trypanosoma cruzi; trypanothione; trypanothione reductase;
D O I
10.1006/abio.1998.3061
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Trypanothione reductases (TR; EC 1.6.4.8) and thioredoxin reductases (TrxR; EC 1.6.4.5.) are enzymes central to cellular thiol metabolism. Trypanosoma cruzi TR (TcTR) is therefore considered as a potential candidate for drug design against trypanosomiasis. Inhibition of human TrxR (hTrxR) is likely to be beneficial in psoriasis, cancer, and autoimmune diseases, while inhibition of a putative TrxR from Plasmodium falciparum (PfTxR) might prove effective against malaria. The natural substrates of the first two enzymes are very expensive and difficult to obtain; in the case of PfTrxR, the physiological substrate has not yet been identified. We have therefore synthesized and tested three different 5,5'-dithiobis(2-nitrobenzamides) as alternative substrates of the above enzymes. As with 5,5'-dithiobis(2-nitrobenzoate) (DTNB), which can be reduced by TRs and TrxRs, the new compounds are converted to their corresponding chromophoric thiolates; however, they have much lower K-m values and are therefore less likely to interfere with inhibitor testing. Using the new substrates, a novel enzyme assay has been developed which is identical for all three enzymes, can be performed in a microtiter plate, and is amenable to automation. Thus, the assay provides a versatile and inexpensive tool for kinetic studies and high-throughput inhibitor screening. (C) 1999 Academic Press.
引用
收藏
页码:1 / 8
页数:8
相关论文
共 38 条
[1]  
Albericio F, 1997, METHOD ENZYMOL, V289, P104
[2]   The mechanism of thioredoxin reductase from human placenta is similar to the mechanisms of lipoamide dehydrogenase and glutathione reductase and is distinct from the mechanism of thioredoxin reductase from Escherichia coli [J].
Arscott, LD ;
Gromer, S ;
Schirmer, RH ;
Becker, K ;
Williams, CH .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (08) :3621-3626
[3]   A MICROPLATE ASSAY FOR TRYPANOTHIONE REDUCTASE INHIBITORS [J].
AUMERCIER, M ;
MEZIANECHERIF, D ;
MOUTIEZ, M ;
TARTAR, A ;
SERGHERAERT, C .
ANALYTICAL BIOCHEMISTRY, 1994, 223 (01) :161-164
[4]   2-amino diphenylsulfides as inhibitors of trypanothione reductase: Modification of the side chain [J].
Baillet, S ;
Buisine, E ;
Horvath, D ;
Maes, L ;
Bonnet, B ;
Sergheraert, C .
BIOORGANIC & MEDICINAL CHEMISTRY, 1996, 4 (06) :891-899
[5]   A glutathione reductase-like flavoenzyme of the malaria parasite Plasmodium falciparum: Structural considerations based on the DNA sequence [J].
Becker, K ;
Muller, S ;
Keese, MA ;
Walter, RD ;
Schirmer, RH .
BIOCHEMICAL SOCIETY TRANSACTIONS, 1996, 24 (01) :67-72
[6]   RATIONALLY DESIGNED SELECTIVE INHIBITORS OF TRYPANOTHIONE REDUCTASE - PHENOTHIAZINES AND RELATED TRICYCLICS AS LEAD STRUCTURES [J].
BENSON, TJ ;
MCKIE, JH ;
GARFORTH, J ;
BORGES, A ;
FAIRLAMB, AH ;
DOUGLAS, KT .
BIOCHEMICAL JOURNAL, 1992, 286 :9-11
[7]   New spermine and spermidine derivatives as potent inhibitors of Trypanosoma cruzi trypanothione reductase [J].
Bonnet, B ;
Soullez, D ;
DavioudCharvet, E ;
Landry, V ;
Horvath, D ;
Sergheraert, C .
BIOORGANIC & MEDICINAL CHEMISTRY, 1997, 5 (07) :1249-1256
[8]   SYNTHESIS OF N-BENZYLOXYCARBONYL-L-CYSTEINYLGLYCINE 3-DIMETHYLAMINOPROPYLAMIDE DISULFIDE - A CHEAP AND CONVENIENT NEW ASSAY FOR TRYPANOTHIONE REDUCTASE [J].
ELWAER, A ;
DOUGLAS, KT ;
SMITH, K ;
FAIRLAMB, AH .
ANALYTICAL BIOCHEMISTRY, 1991, 198 (01) :212-216
[9]  
ELWAER AF, 1993, INT J PEPT PROT RES, V41, P141
[10]   Charge is the major discriminating factor for glutathione reductase versus trypanothione reductase inhibitors [J].
Faerman, CH ;
Savvides, SN ;
Strickland, C ;
Breidenbach, MA ;
Ponasik, JA ;
Ganem, B ;
Ripoll, D ;
KrauthSiegel, RL ;
Karplus, PA .
BIOORGANIC & MEDICINAL CHEMISTRY, 1996, 4 (08) :1247-1253